Abstract
A series of 4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides were synthesized and evaluated for antibacterial and antifungal activities against Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), methicillin-resistant S. epidermis (MRSE), Enterococcus faecalis, Escherichia coli and Candida albicans. Certain compounds inhibit bacterial growth with low MIC values (microg/mL). Among them, compounds 10 and 11 exhibited the greatest antibacterial activity with MIC values of 3.12 microg/mL against S. aureus, MRSA and MRSE.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / chemical synthesis*
-
Anti-Bacterial Agents / chemistry
-
Anti-Bacterial Agents / pharmacology
-
Antifungal Agents / chemical synthesis*
-
Antifungal Agents / chemistry
-
Antifungal Agents / pharmacology
-
Benzamides / chemical synthesis*
-
Benzamides / chemistry
-
Benzamides / pharmacology
-
Candida albicans / drug effects
-
Enterococcus faecalis / drug effects
-
Escherichia coli / drug effects
-
Methicillin Resistance
-
Microbial Sensitivity Tests
-
Staphylococcus aureus / drug effects
-
Staphylococcus epidermidis / drug effects
-
Structure-Activity Relationship
Substances
-
Anti-Bacterial Agents
-
Antifungal Agents
-
Benzamides